Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The hemoglobin digestion pathway is a critical metabolic process in blood-feeding parasites such as Plasmodium falciparum and ticks. It involves the uptake and enzymatic breakdown of host hemoglobin within the parasite's digestive vacuole to provide essential amino acids for growth and survival, while also detoxifying the toxic heme byproduct through hemozoin formation. This pathway is essential for parasite survival and is a validated drug target for antimalarial and anti-tick therapeutics, wherein disruption of these processes leads to death of the organism.
Inhibition of hemoglobin degradation or hemozoin formation
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hemoglobin Digestion Pathway.